Physician profile
Ryan Michael Gobble
NPI 1740452317
$2,564.62
in general payments reported to CMS, 2019-2025
9 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what 82% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $37.00 · 2021: $34.86 · 2022: $171 · 2023: $171 · 2024: $243 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,500 · Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,500.31 |
| Food and Beverage | $711.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,772.79 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Mentor Worldwide LLC | $291.94 | 2020-2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 4 Breast Tissue Expander |
| Tela Bio, INC. | $166.41 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Axogen | $94.38 | 2019 | |
| Allergan, INC. | $88.42 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $85.28 | 2022 | |
| Sientra, INC. | $26.18 | 2020-2021 | |
| Sanara Medtech INC. | $22.26 | 2021 | |
| Smith+Nephew, INC. | $16.96 | 2023 | Pico 14 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gobble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.